# Zivo Bioscience, Inc.: Form SCHEDULE 13D/A, filed Feb 27, 2026

- Company: [Zivo Bioscience, Inc.](/companies/zivo.md) (CIK 1101026)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-27
- Accepted by EDGAR: Feb 27, 2026, 20:20 ET
- Period: not reported
- Accession: 0001213900-26-021894
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1101026/000121390026021894/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1101026/000121390026021894/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1101026/000121390026021894/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-021894. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
